MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30273% above fair value
$3.96−0.17 (-4.24%)
Close on Nov 16, 2026Market cap $1.27BP/E –Yield –
MannKind cash
Cash and short-term investments held at the end of each period.
MannKind's cash was $96.61M at Sep 30, 2026. For fiscal 2025 it was $171.35M, down 13.1% from the year before. Over ten years it grew 11.2% a year on average. The highest annual figure on record is $295.10M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $171.35M | -13.1% |
| FY2024 | Dec 31, 2024 | $197.26M | -33.2% |
| FY2023 | Dec 31, 2023 | $295.10M | +72.7% |
| FY2022 | Dec 31, 2022 | $170.85M | -16.3% |
| FY2021 | Dec 31, 2021 | $204.12M | +204.6% |
| FY2020 | Dec 31, 2020 | $67.01M | +34.3% |
| FY2019 | Dec 31, 2019 | $49.88M | -29.9% |
| FY2018 | Dec 31, 2018 | $71.16M | +61.9% |
| FY2017 | Dec 31, 2017 | $43.95M | +91.9% |
| FY2016 | Dec 31, 2016 | $22.90M | -61.2% |
| FY2015 | Dec 31, 2015 | $59.07M | -51.1% |
| FY2014 | Dec 31, 2014 | $120.84M | +70.7% |
| FY2013 | Dec 31, 2013 | $70.79M | +14.5% |
| FY2012 | Dec 31, 2012 | $61.84M | +2206.6% |
| FY2011 | Dec 31, 2011 | $2.68M | -95.9% |
| FY2010 | Dec 31, 2010 | $66.06M | +120.1% |
| FY2009 | Dec 31, 2009 | $30.02M | +8.6% |
| FY2008 | Dec 31, 2008 | $27.65M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $96.61M | -62.8% |
| Q2 FY2026 | Jun 30, 2026 | $111.13M | -37.9% |
| Q1 FY2026 | Mar 31, 2026 | $133.86M | -26.3% |
| Q4 FY2025 | Dec 31, 2025 | $171.35M | -13.1% |
| Q3 FY2025 | Sep 30, 2025 | $260.04M | +3.4% |
| Q2 FY2025 | Jun 30, 2025 | $178.99M | -27.8% |
| Q1 FY2025 | Mar 31, 2025 | $181.54M | -39.6% |
| Q4 FY2024 | Dec 31, 2024 | $197.26M | -33.2% |
| Q3 FY2024 | Sep 30, 2024 | $251.59M | +78.4% |
| Q2 FY2024 | Jun 30, 2024 | $247.76M | +71.6% |
| Q1 FY2024 | Mar 31, 2024 | $300.73M | +81.0% |
| Q4 FY2023 | Dec 31, 2023 | $295.10M | +72.7% |
| Q3 FY2023 | Sep 30, 2023 | $141.02M | -14.6% |
| Q2 FY2023 | Jun 30, 2023 | $144.35M | -6.4% |
| Q1 FY2023 | Mar 31, 2023 | $166.14M | +2.3% |
| Q4 FY2022 | Dec 31, 2022 | $170.85M | -16.3% |
| Q3 FY2022 | Sep 30, 2022 | $165.05M | +18.7% |
| Q2 FY2022 | Jun 30, 2022 | $154.16M | -5.1% |
| Q1 FY2022 | Mar 31, 2022 | $162.45M | -41.3% |
| Q4 FY2021 | Dec 31, 2021 | $204.12M | +204.6% |
| Q3 FY2021 | Sep 30, 2021 | $139.05M | +165.4% |
| Q2 FY2021 | Jun 30, 2021 | $162.49M | +157.0% |
| Q1 FY2021 | Mar 31, 2021 | $276.80M | +612.1% |
| Q4 FY2020 | Dec 31, 2020 | $67.01M | +34.3% |
| Q3 FY2020 | Sep 30, 2020 | $52.40M | +4.7% |
| Q2 FY2020 | Jun 30, 2020 | $63.22M | +92.3% |
| Q1 FY2020 | Mar 31, 2020 | $38.87M | -34.4% |
| Q4 FY2019 | Dec 31, 2019 | $49.88M | -29.9% |
| Q3 FY2019 | Sep 30, 2019 | $50.06M | +379.2% |
| Q2 FY2019 | Jun 30, 2019 | $32.88M | +25.6% |
| Q1 FY2019 | Mar 31, 2019 | $59.29M | +122.0% |
| Q4 FY2018 | Dec 31, 2018 | $71.16M | +61.9% |
| Q3 FY2018 | Sep 30, 2018 | $10.45M | -48.0% |
| Q2 FY2018 | Jun 30, 2018 | $26.18M | -39.7% |
| Q1 FY2018 | Mar 31, 2018 | $26.71M | -44.3% |
| Q4 FY2017 | Dec 31, 2017 | $43.95M | +91.9% |
| Q3 FY2017 | Sep 30, 2017 | $20.09M | – |
| Q2 FY2017 | Jun 30, 2017 | $43.38M | – |
| Q1 FY2017 | Mar 31, 2017 | $47.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $22.90M | – |
See a number that looks wrong?